Answers are grounded in this paper and cite their sources.
Demonstrates that halogenated bisphenol A derivatives inhibit placental 3β-hydroxysteroid dehydrogenases and reduce progesterone, indicating potential endocrine risks during pregnancy.
Halogenated bisphenol A (BPA) derivatives are extensively utilized in industrial production and have been detected in the environment, as well as in human samples. The 3β-HSDs are important for the catalytic transformation of pregnenolone into progesterone. But inhibition by BPA derivatives on 3β-HSD activity is still unclear. The inhibition of 3β-HSD by 8 halogen BPA derivatives was assessed by means of an in vitro test. Tetrachloro BPA was found to be the strongest 3β-HSDs in both human and rat models with IC 50 values of 1.48 and 3.81 μM. Other derivatives, including 3-chloro BPA, bisphenol C, 3,3’,5-trichloro BPA, tetrabromo BPA, and 4,4’-thiodiphenol, also exhibited inhibitory effects on human and rat placental 3β-HSD activity, albeit with lower potency. 3-Chloro BPA and bisphenol C exerted mixed inhibition against human 3β-HSD1, while the others functioned as competitive inhibitors. These compounds significantly suppressed progesterone secretion in human JAr cells. The inhibitory effects were inversely correlated with the Log P (lipophilicity) and halogen atoms. Docking analysis showed hydrophobic and hydrogen bond interactions that played key roles in the inhibition mechanism. In this paper, a new pharmacological model, which includes both hydrophobic and aromatics, has been proposed for the prediction of inhibition of BPA derivatives. In summary, some halogen-containing derivatives are strong suppressors of 3β-HSDs in placenta, and the inhibition effect of these compounds is mainly dependent on the lipophilicity.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: